Yen-Jun Chuang

TL;DR: A new optical read-out form, photostimulated persistent luminescence (PSPL) in the near-infrared (NIR), from a Cr3+-doped LiGa5O8 NIR persistent phosphor exhibiting a super-long N IR persistent Luminescence of more than 1,000 h is reported.

TL;DR: A novel X-ray inducible photodynamic therapy (X-PDT) approach that allows PDT to be regulated by X-rays and cause efficient tumor shrinkage is reported.

TL;DR: A photodynamic therapy (PDT)-based EPR enhancement technology that uses RGD-modified ferritin (RFRT) as “smart” carriers that site-specifically deliver 1O2 to the tumor endothelium is introduced and has proven to be safe, selective, and effective.

TL;DR: A new technology called red blood cell (RBC)‐facilitated PDT, or RBC‐PDT, is introduced that can potentially solve the issue of low O2 levels in tumors and is expected to find wide applications in modern oncology.

TL;DR: A novel type of optical nanoprobes, photostimulable LiGa5O8:Cr3+ near-infrared (NIR) persistent Luminescence nanoparticles, which, with very-long-lasting NIR persistent luminescence and unique photo-stimulated persistent luminecence (PSPL) capability, allow optical imaging to be performed in an excitation-free and hence, autofluorescence-free manner.